Comment on: "Oral Disease-Modifying Treatments for Relapsing Multiple Sclerosis: A Likelihood to Achieve No Evidence of Disease Activity or Harm Analysis". Επικοινωνία Submitted by Δημήτρης Σπάχος on Παρ, 12/04/2020 - 16:41
